Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report issued on Monday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Down 1.8 %

Shares of NYSE:RVP opened at $1.09 on Monday. The company has a 50 day moving average of $1.09 and a 200-day moving average of $1.15. The firm has a market cap of $32.63 million, a P/E ratio of -4.19 and a beta of 2.08. Retractable Technologies has a twelve month low of $0.87 and a twelve month high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVPGet Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $7.60 million during the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Insider Activity at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw bought 48,635 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was acquired at an average cost of $1.03 per share, with a total value of $50,094.05. Following the completion of the purchase, the chief executive officer now directly owns 14,417,148 shares in the company, valued at $14,849,662.44. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders acquired a total of 150,816 shares of company stock valued at $156,305 over the last ninety days. Insiders own 55.00% of the company’s stock.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.